We showed that participants with greater MDS indicated reduced NF-κB activity in peripheral blood mononuclear cells, reduced circulating inflammatory markers (IL-1β) and increased adipokines (adiponectin and adipsin), findings that are in line with other literature [43,44]. The gene discussed is ADIPOQ; the disease is myelodysplastic syndrome.